Fingerprint
Dive into the research topics of 'Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
Andreas Papapetropoulos*, Stavros Topouzis, Steve P. H. Alexander, Miriam Cortese‐Krott, Dave A. Kendall, Kirill A. Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Mauro M. Teixeira, Nathalie Vergnolle, Xin Wang, Péter Ferdinandy
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
212
Downloads
(Pure)